Response to 'COVID-19-associated multisystem inflammatory syndrome in adults with Kawasaki disease-like cutaneous manifestations': reply from the authors

Br J Dermatol. 2021 Oct;185(4):872-873. doi: 10.1111/bjd.20638. Epub 2021 Sep 28.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Adult
  • COVID-19*
  • Humans
  • Mucocutaneous Lymph Node Syndrome* / complications
  • Mucocutaneous Lymph Node Syndrome* / drug therapy
  • SARS-CoV-2